Pre- and Postoperative Chest Therapy With Positive Expiratory Pressure (PEP) to Prevent Hospital-acquired Pneumonia in Patients Undergoing Hip Fracture Surgery

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to investigate whether pre- and postoperative treatment with systematic PEP therapy can prevent hospital-acquired pneumonia in patients with hip frac-ture. It will also learn about the barriers regarding PEP therapy in this group of patients. * Does pre- and postoperative treatment with systematic PEP therapy prevent hospital-acquired pneumonia in patients with hip fracture? * Which barriers do participants have regarding PEP therapy in this group of patients? Researchers will compare systematic PEP therapy to no intervention besides standard treat-ment to see if systematic therapy with PEP can prevent hospital-acquired pneumonia. Participants will: * Receive systematic PEP therapy during hospitalization or no intervention besides standard treatment * Register the PEP therapy four times daily on a paper checklist. Failure to perform the treatment and the reason must also be documented on the checklist.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Hip fracture regardless of age

• Cognitively well-functioning

• Able to understand the study and give informed consent

• Able to speak and understand Danish

• Resident of Region Hovedstaden or Region Sjælland

Locations
Other Locations
Denmark
Bispebjerg & Frederiksberg Hospital
RECRUITING
Copenhagen
Herlev & Gentofte Hospital
RECRUITING
Herlev
Time Frame
Start Date: 2024-02-19
Estimated Completion Date: 2030-12-31
Participants
Target number of participants: 566
Treatments
Active_comparator: Active
Medical therapy device
No_intervention: Standard treatment
Standard treatment
Related Therapeutic Areas
Sponsors
Leads: University Hospital Bispebjerg and Frederiksberg

This content was sourced from clinicaltrials.gov